www.babynosis.com

Scientific Overview

Babynosis™ is a patent-pending early-childhood technology company positioned to create a new category at the intersection of ethical AI, nervous-system development, emotional regulation, and developmental well-being. The company is focused on supporting children during the earliest and most formative years of life.

Our first product, MindCalm™, is an AI-guided platform that delivers developmentally designed audio experiences for babies and young children. Through storytelling, guided language, sound, affirmations, and calming experiences, MindCalm is designed to help parents incorporate positive developmental practices into a child's daily routine, including bedtime.

Babynosis is built around the understanding that early childhood is a critical period for developing emotional and behavioral foundations. The platform is designed to support parents in nurturing these foundations in a simple, accessible way while creating opportunities for personalized experiences as the child develops.

Early beta testing produced 100% positive participant feedback, providing strong initial validation of the concept and user experience and supporting the next phase of product development, expanded testing, and formal research.

Our customers are parents and caregivers of young children, with future applications designed to address a broader range of developmental needs, including children with diverse learning and developmental profiles.

Babynosis operates on a direct-to-consumer digital subscription model, with MindCalm serving as the first product within a larger platform vision. The company is founder-led and is building relationships with technology, scientific, developmental, and creative collaborators as the platform progresses.

In parallel with private investment, Babynosis is pursuing opportunities for non-dilutive research and development funding to support scientific validation and continued technology development. This strategy is designed to extend investor capital while advancing the company's research and development objectives.

The long-term vision is to establish Babynosis as a new category of early-childhood developmental technology and build a scalable platform capable of supporting children and families across multiple developmental needs and stages.